Skip to content
The GLP-1 Verdict
Menu
Ranked #21 · Grade B

Telos Rx review

Carries one of the deepest published catalogs on the board — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.

Visit Telos Rx Assume we may earn a commission, at no cost to you. It never changes The Verdict Score.
Semaglutide
$49/mo (microdosed, annual)
Tirzepatide
$99/mo (annual)
Coverage
Not publicly listed
Brand-name
Compounded only

The scorecard

Telos Rx scored on our six published factors. See the methodology.

Real-world results83/100
Price honesty82/100
Prescriber access87/100
Formulary choice92/100
Cancellation fairness83/100
Member support84/100

What we like

  • Unusually deep published menu — compounded semaglutide and tirzepatide alongside PT-141, intranasal NAD+, and recovery peptides (sermorelin, ipamorelin, CJC-1295, BPC-157)
  • Needle-free and oral routes, including oral and microdosed tirzepatide, for the needle-averse
  • LegitScript-certified and HIPAA-compliant, with US-based providers and pharmacies, plus HSA/FSA and free 48-hour shipping
  • Low published GLP-1 entry — from $49/mo microdosed and $99/mo tirzepatide on annual plans

The caveats

  • Everything is compounded, not FDA-approved — including the peptides, several of which are research-grade with limited human evidence
  • Pricing turns opaque outside the headline GLP-1 tiers, and the cheapest rates require a long annual lock-in (short plans run $145/$199/$399 in the first month)
  • No named clinicians or leadership, and only a thin body of public reviews
  • States served are not published, so confirm your state is covered before you sign up

The verdict

Best for: Patients who want a single LegitScript-verified operator carrying far more than a GLP-1 — oral and microdosed options, peptides and bioidentical HRT — and will accept compounded-only meds and a long annual lock-in in exchange for the lowest published prices. Carries one of the deepest published catalogs on the board — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.

Ranked #21 of 32 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 31 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Telos Rx's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Telos Rx's site. Not medical advice; see our disclosure.

← Back to all rankings